You are here

05-09-2018

3041Investigating the uncertain future of teaching profession

Teaching is certainly one of the most important professions in our society, yet its status and attractiveness have been systematically diminishing in the last decades. At the Université catholique de Louvain, Prof. Xavier Dumay is using his ERC Starting Grant to investigate the cultural and institutional transformations that have led to this "teaching profession crisis".

29-06-2018

2935Organoids in the fight against cancer

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths. European researchers developed novel ex vivo three-dimensional organoid cultures that replicate genetic events in CRC, as tools to test novel therapeutics.

18-04-2018

2829Going mainstream: why and how disruptive innovations in mobility are adopted

Peer pressure plays an important role in spreading new trends and habits. But what impact does social influence have in the diffusion of disruptive innovations that challenge prevailing transport technologies and mobility practices? Funded by the ERC, a team led by Dr Charlie Wilson is looking into this matter.

16-04-2018

2821How do pedestrians and cyclists move in traffic?

In urban areas, an increasing number of travellers are turning to more sustainable means of transport such as walking and cycling. The ALLEGRO project studies pedestrians and cyclists’ behaviour in traffic, a field that offers many opportunities for ground-breaking knowledge.

16-04-2018

2824Towards smarter traffic control

Severe traffic jams not only have an impact on mobility, they also raise environmental and health issues linked to fuel consumption and air and noise pollution. Prof. Ludovic Leclercq is developing new traffic control models that could tackle road congestion while integrating a green dimension.

18-12-2017

2677Learning from Diversity

Could migration lead to more respect for ethnic and cultural diversity not only in receiving communities but also in sending countries? By observing the effects of Polish migration to the UK and Germany, as a result of the country’s entry in the EU in 2004, Prof. Magdalena Nowicka explores possible answers to this question.

16-06-2017

2253What kind of support is needed for unaccompanied refugee minors?

Almost 30 million children across the world are currently forcibly displaced and many of them, the unaccompanied refugee minors, are travelling without the protection and support of parents or caregivers. What do we know about the impact of their often harsh experiences on their psychological wellbeing? Dr llse Derluyn aims to gather evidence that will support the development of policies and clinical and social interventions for these unaccompanied children who face multiple traumas, also in a view to facilitate their integration in the host countries. 

28-04-2017

2047Behind the wall: uncovering the effectiveness of migration policy

Comprehensive new databases of migration flows and policy data since World War II highlight how some policies have had unintended effects.

01-04-2017

2992Frontier science and business that makes a difference

Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

30-11-2016

1332Gut bacteria could hold key to new treatments

An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.